GCG and type 2 diabetes mellitus: More importantly, liraglutide, a GLP-1 agonist currently used clinically for the treatment of type 2 diabetes (T2D), exerts a potent central thermogenic action, in addition to inducing browning of WAT, by modulating AMPK specifically in the VMH among tested hypothalamic sites (46).